74 related articles for article (PubMed ID: 23765652)
21. Metabolic glycoengineering through the mammalian GalNAc salvage pathway.
Pouilly S; Piller V; Piller F
FEBS J; 2012 Feb; 279(4):586-98. PubMed ID: 22151230
[TBL] [Abstract][Full Text] [Related]
22. Roles of mucin-type O-glycans synthesized by core2beta1,6-N-acetylglucosaminyltransferase.
Fukuda M
Methods Enzymol; 2006; 416():332-46. PubMed ID: 17113877
[TBL] [Abstract][Full Text] [Related]
23. beta1,4-N-Acetylglucosaminyltransferase III potentiates beta1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells.
Shigeta M; Shibukawa Y; Ihara H; Miyoshi E; Taniguchi N; Gu J
Glycobiology; 2006 Jun; 16(6):564-71. PubMed ID: 16531477
[TBL] [Abstract][Full Text] [Related]
24. Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma cells.
Brockhausen I; Romero PA; Herscovics A
Cancer Res; 1991 Jun; 51(12):3136-42. PubMed ID: 1904002
[TBL] [Abstract][Full Text] [Related]
25. Simple sugars to complex disease--mucin-type O-glycans in cancer.
Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
[TBL] [Abstract][Full Text] [Related]
26. Characterization of mice with targeted deletion of the gene encoding core 2 beta1,6-N-acetylglucosaminyltransferase-2.
Stone EL; Lee SH; Ismail MN; Fukuda M
Methods Enzymol; 2010; 479():155-72. PubMed ID: 20816165
[TBL] [Abstract][Full Text] [Related]
27. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
Lange T; Ullrich S; Müller I; Nentwich MF; Stübke K; Feldhaus S; Knies C; Hellwinkel OJ; Vessella RL; Abramjuk C; Anders M; Schröder-Schwarz J; Schlomm T; Huland H; Sauter G; Schumacher U
Clin Cancer Res; 2012 Mar; 18(5):1364-73. PubMed ID: 22261809
[TBL] [Abstract][Full Text] [Related]
28. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
29. BOLD--a biological O-linked glycan database.
Cooper CA; Wilkins MR; Williams KL; Packer NH
Electrophoresis; 1999 Dec; 20(18):3589-98. PubMed ID: 10612285
[TBL] [Abstract][Full Text] [Related]
30. Complex N-glycan and metabolic control in tumor cells.
Mendelsohn R; Cheung P; Berger L; Partridge E; Lau K; Datti A; Pawling J; Dennis JW
Cancer Res; 2007 Oct; 67(20):9771-80. PubMed ID: 17942907
[TBL] [Abstract][Full Text] [Related]
31. Mucin-type proteins produced in the Trichoplusia ni and Spodoptera frugiperda insect cell lines carry novel O-glycans with phosphocholine and sulfate substitutions.
Gaunitz S; Jin C; Nilsson A; Liu J; Karlsson NG; Holgersson J
Glycobiology; 2013 Jul; 23(7):778-96. PubMed ID: 23463814
[TBL] [Abstract][Full Text] [Related]
32. N-Glycans in cancer progression.
Lau KS; Dennis JW
Glycobiology; 2008 Oct; 18(10):750-60. PubMed ID: 18701722
[TBL] [Abstract][Full Text] [Related]
33. An N-acetylglucosaminyltransferase of the Golgi apparatus of the yeast Saccharomyces cerevisiae that can modify N-linked glycans.
Yoko-o T; Wiggins CA; Stolz J; Peak-Chew SY; Munro S
Glycobiology; 2003 Aug; 13(8):581-9. PubMed ID: 12651885
[TBL] [Abstract][Full Text] [Related]
34. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
Hodoniczky J; Zheng YZ; James DC
Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
[TBL] [Abstract][Full Text] [Related]
35. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans.
An G; Wei B; Xia B; McDaniel JM; Ju T; Cummings RD; Braun J; Xia L
J Exp Med; 2007 Jun; 204(6):1417-29. PubMed ID: 17517967
[TBL] [Abstract][Full Text] [Related]
36. Expression of the high-affinity selectin glycan ligand C2-O-sLeX by colon carcinoma cells.
St Hill CA; Bullard KM; Walcheck B
Cancer Lett; 2005 Jan; 217(1):105-13. PubMed ID: 15596301
[TBL] [Abstract][Full Text] [Related]
37. C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells.
Huang MC; Chen HY; Huang HC; Huang J; Liang JT; Shen TL; Lin NY; Ho CC; Cho IM; Hsu SM
Oncogene; 2006 Jun; 25(23):3267-76. PubMed ID: 16418723
[TBL] [Abstract][Full Text] [Related]
38. Substitutions in the N-glycan core as regulators of biorecognition: the case of core-fucose and bisecting GlcNAc moieties.
André S; Kozár T; Schuberth R; Unverzagt C; Kojima S; Gabius HJ
Biochemistry; 2007 Jun; 46(23):6984-95. PubMed ID: 17497937
[TBL] [Abstract][Full Text] [Related]
39. Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus-associated core 2 beta1, 6-n-acetylglucosaminyltransferase.
Schwientek T; Yeh JC; Levery SB; Keck B; Merkx G; van Kessel AG; Fukuda M; Clausen H
J Biol Chem; 2000 Apr; 275(15):11106-13. PubMed ID: 10753916
[TBL] [Abstract][Full Text] [Related]
40. Roles of mucin-type O-glycans in cell adhesion.
Fukuda M
Biochim Biophys Acta; 2002 Dec; 1573(3):394-405. PubMed ID: 12417424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
